EPAM Systems Inc (EPAM)
Official siteTECHNOLOGY • INFORMATION TECHNOLOGY SERVICES • NYSE
Market Cap: $8.32B
Last updated: Nov 17, 2026 at 11:05 AM ET
EPAM Systems Inc (EPAM) Earnings: Report Dates and Results
EPAM Systems (EPAM) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, EPAM Systems reported EPS of $3.19, above the $2.76 estimate. It beat the EPS estimate in each of the last 37 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
EPAM has an expected report date of Feb 17, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 10.7% above the $3.26 reported for the quarter ended Dec 31, 2025.
EPAM Earnings Call
The latest EPAM earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 40 quarters below that had an estimate, EPAM beat 37 and missed 3. Revenue for the quarter ended Sep 30, 2026 was $1.43B, up 2.9% from $1.39B a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $3.19 | $2.76 | N/A | +15.58% | Beat | +3.6% | 17 | 2 up, 14 down | Nov 5, 2026 | $1.43B |
| Jun 30, 2026 | $2.93 | $2.44 | N/A | +20.08% | Beat | +40.2% | 17 | 0 up, 2 down | Aug 6, 2026 | $1.41B |
| Mar 31, 2026 | $2.86 | $2.75 | $2.73 - $2.79 | +4.00% | Beat | +18.7% | 17 | 7 up, 6 down | May 7, 2026 | $1.40B |
| Dec 31, 2025 | $3.26 | $3.16 | $3.12 - $3.21 | +3.16% | Beat | +14.8% | 16 | 1 up, 0 down | Feb 19, 2026 | $1.41B |
| Sep 30, 2025 | $3.08 | $3.03 | $2.99 - $3.08 | +1.65% | Beat | -1.3% | 15 | 2 up, 0 down | Nov 6, 2025 | $1.39B |
| Jun 30, 2025 | $2.09 | $2.07 | N/A | +0.97% | Beat | -14.7% | 15 | 3 up, 1 down | Aug 7, 2025 | $1.35B |
| Mar 31, 2025 | $2.41 | $2.27 | $2.18 - $2.32 | +6.17% | Beat | -2.0% | 17 | 1 up, 4 down | May 8, 2025 | $1.30B |
| Dec 31, 2024 | $2.84 | $2.75 | $2.69 - $2.78 | +3.27% | Beat | +3.3% | 17 | 3 up, 1 down | Feb 20, 2025 | $1.25B |
| Sep 30, 2024 | $3.12 | $2.70 | $2.67 - $2.75 | +15.56% | Beat | +14.3% | 18 | 3 up, 1 down | Nov 7, 2024 | $1.17B |
| Jun 30, 2024 | $2.45 | $2.26 | $2.21 - $2.29 | +8.41% | Beat | -7.2% | 19 | 4 up, 0 down | Aug 8, 2024 | $1.15B |
| Mar 31, 2024 | $2.46 | $2.31 | $2.26 - $2.40 | +6.49% | Beat | -0.4% | 18 | 0 up, 2 down | May 9, 2024 | $1.17B |
| Dec 31, 2023 | $2.75 | $2.50 | $2.28 - $2.57 | +10.00% | Beat | -6.1% | 17 | 2 up, 0 down | Feb 15, 2024 | $1.16B |
| Sep 30, 2023 | $2.73 | $2.56 | $2.49 - $2.60 | +6.64% | Beat | -11.9% | 16 | 1 up, 1 down | Nov 2, 2023 | $1.15B |
| Jun 30, 2023 | $2.64 | $2.34 | $2.27 - $2.38 | +12.82% | Beat | +10.9% | 15 | 0 up, 0 down | Aug 3, 2023 | $1.17B |
| Mar 31, 2023 | $2.47 | $2.34 | $2.31 - $2.36 | +5.56% | Beat | -0.8% | 15 | 2 up, 1 down | May 5, 2023 | $1.21B |
| Dec 31, 2022 | $2.93 | $2.68 | $2.62 - $2.74 | +9.33% | Beat | +6.2% | 15 | 1 up, 0 down | Feb 16, 2023 | $1.23B |
| Sep 30, 2022 | $3.10 | $2.53 | $2.46 - $2.76 | +22.53% | Beat | +28.1% | 13 | 2 up, 0 down | Nov 3, 2022 | $1.23B |
| Jun 30, 2022 | $2.38 | $1.71 | $1.64 - $1.85 | +39.18% | Beat | +16.1% | 13 | 0 up, 0 down | Aug 4, 2022 | $1.19B |
| Mar 31, 2022 | $2.49 | $1.77 | $0.76 - $2.70 | +40.68% | Beat | +37.6% | 14 | 2 up, 0 down | May 5, 2022 | $1.17B |
| Dec 31, 2021 | $2.76 | $2.51 | $2.47 - $2.60 | +9.96% | Beat | +52.5% | 14 | 1 up, 0 down | Feb 17, 2022 | $1.11B |
| Sep 30, 2021 | $2.42 | $2.22 | $2.19 - $2.30 | +9.01% | Beat | +46.7% | 15 | N/A | Nov 4, 2021 | $988.54M |
| Jun 30, 2021 | $2.05 | $1.94 | $1.90 - $2.01 | +5.67% | Beat | +40.4% | 16 | N/A | Aug 5, 2021 | $881.37M |
| Mar 31, 2021 | $1.81 | $1.69 | $1.65 - $1.74 | +7.10% | Beat | +26.6% | 15 | N/A | May 6, 2021 | $780.77M |
| Dec 31, 2020 | $1.81 | $1.71 | $1.67 - $1.77 | +5.85% | Beat | +19.9% | 16 | N/A | Feb 18, 2021 | $723.49M |
| Sep 30, 2020 | $1.65 | $1.47 | $1.42 - $1.55 | +12.24% | Beat | +18.7% | 15 | N/A | Nov 5, 2020 | $652.24M |
| Jun 30, 2020 | $1.46 | $1.21 | $1.13 - $1.25 | +20.66% | Beat | +14.1% | 15 | N/A | Aug 6, 2020 | $632.38M |
| Mar 31, 2020 | $1.43 | $1.40 | $1.36 - $1.47 | +2.14% | Beat | +14.4% | 15 | N/A | May 7, 2020 | $651.36M |
| Dec 31, 2019 | $1.51 | $1.45 | $1.43 - $1.47 | +4.14% | Beat | +18.9% | 14 | N/A | Feb 20, 2020 | $632.77M |
| Sep 30, 2019 | $1.39 | $1.34 | $1.32 - $1.34 | +3.73% | Beat | +18.8% | 13 | N/A | Nov 7, 2019 | $588.10M |
| Jun 30, 2019 | $1.28 | $1.23 | $1.21 - $1.28 | +4.07% | Beat | +26.7% | 13 | N/A | Aug 8, 2019 | $551.59M |
| Mar 31, 2019 | $1.25 | $1.17 | $1.15 - $1.18 | +6.84% | Beat | +34.4% | 12 | N/A | May 9, 2019 | $521.33M |
| Dec 31, 2018 | $1.27 | $1.23 | $1.21 - $1.23 | +3.25% | Beat | +25.7% | 14 | N/A | Feb 14, 2019 | $504.93M |
| Sep 30, 2018 | $1.17 | $1.06 | $1.03 - $1.08 | +10.38% | Beat | +27.2% | 13 | N/A | Nov 1, 2018 | $468.19M |
| Jun 30, 2018 | $1.01 | $0.99 | $0.98 - $1.00 | +2.02% | Beat | +26.2% | 14 | N/A | Aug 2, 2018 | $445.65M |
| Mar 31, 2018 | $0.93 | $0.91 | $0.89 - $0.93 | +2.20% | Beat | +29.2% | 16 | N/A | May 9, 2018 | $424.15M |
| Dec 31, 2017 | $1.01 | $0.97 | $0.95 - $1.00 | +4.12% | Beat | +31.2% | 15 | N/A | Feb 16, 2018 | $399.30M |
| Sep 30, 2017 | $0.92 | $0.85 | $0.84 - $0.87 | +8.24% | Beat | +21.1% | 13 | N/A | Nov 2, 2017 | $377.52M |
| Jun 30, 2017 | $0.80 | $0.81 | $0.80 - $0.83 | -1.23% | Miss | +12.7% | 12 | N/A | Aug 3, 2017 | $348.98M |
| Mar 31, 2017 | $0.72 | $0.74 | N/A | -2.70% | Miss | 0.0% | N/A | N/A | May 4, 2017 | $324.65M |
| Dec 31, 2016 | $0.77 | $0.78 | N/A | -1.28% | Miss | -1.3% | N/A | N/A | Feb 16, 2017 | $313.52M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $10.84, within 4 cents of the year before. It was $2.96 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $10.84 | N/A |
| Dec 31, 2024 | $10.87 | +2.6% |
| Dec 31, 2023 | $10.59 | -2.8% |
| Dec 31, 2022 | $10.90 | +20.6% |
| Dec 31, 2021 | $9.04 | +42.4% |
| Dec 31, 2020 | $6.35 | +16.9% |
| Dec 31, 2019 | $5.43 | +24.0% |
| Dec 31, 2018 | $4.38 | +27.0% |
| Dec 31, 2017 | $3.45 | +16.6% |
| Dec 31, 2016 | $2.96 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,800 words across 13 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 8,839 | 13 | |
| 2026Q2 | Jun 30, 2026 | 8,355 | 12 | |
| 2026Q1 | Mar 31, 2026 | 6,644 | 14 | |
| 2025Q4 | Dec 31, 2025 | 8,288 | 12 | |
| 2025Q3 | Sep 30, 2025 | 6,243 | 14 | |
| 2025Q2 | Jun 30, 2025 | 8,171 | 12 | |
| 2025Q1 | Mar 31, 2025 | 6,695 | 10 | |
| 2024Q4 | Dec 31, 2024 | 7,071 | 10 |
2026Q3 Earnings Call
Opening remarks
Mike Rowshandel Head of Investor Relations Good morning, everyone, and thank you for joining us today on our third-quarter 2026 earnings announcement. As the operator just mentioned, I am Mike Rowshandel, Head of Investor Relations. We hope you have had an opportunity to review our earnings release we issued earlier today. If you have not, copies are available on epam.com in the investors section. With me on today's call are Balázs Fejes, CEO and President, and Jason Peterson, Chief Financial Officer. I would like to remind those listening that some of the comments made on today's call may contain forward-looking statements. These statements are subject to risks and uncertainties as described in the company's earnings release and SEC filings. Additionally, all references to reported results that are non-GAAP measures have been reconciled to the comparable GAAP measures and are available in our quarterly earnings materials in the investors section of our website. With that said, I will now turn the call over to FB.
Balázs Fejes CEO and President Thank you, Mike, and good morning, everyone. It is a pleasure to be with you all again. Today, we are sharing positive progress and results. Our third quarter came in better than expected, outperforming the high end of our outlook range for revenue, profitability, and earnings per share. In the quarter, the company generated over $185 million in AI-native revenues, once again delivering a sequential double-digit growth rate. EPAM now expects to generate at least $650 million in AI-native revenues in 2026, an increase from our original target of $600 million. We accomplished all of this while continuing to transform our core business. We are seeing accelerating momentum in the execution of our strategy and are pleased to deliver on many of the commitments we set out earlier this year. On the new big strategic deals, we signed three in the quarter and continue to progress with deals in our pipeline, which continues to grow. With our strategic partnerships, we are ahead of our plan, both from a capability and enablement standpoint, as well as in terms of building deal-generation motion that puts emphasis on hundreds of production deployments that deliver a unique value proposition with each partner. In October, we launched our new Frontier AI Service, and our new Frontier partnership channels are beginning to generate new opportunities. We are the client zero of our own AI transformation and taking what we learn to clients as proof points. We are also making solid progress on our go-to-market transformation, with North America as the focus. Finally, our full-year outlook now sits at or just above the midpoint of the range we set out in August.
Frequently Asked Questions About EPAM
When is EPAM Systems's next earnings date?
EPAM Systems's next earnings report is expected for Feb 17, 2027.
Did EPAM beat earnings estimates last quarter?
Yes. EPAM Systems reported EPS of $3.19 for the quarter ended Sep 30, 2026, above the $2.76 estimate, a 15.58% surprise.
What EPS do analysts expect from EPAM next quarter?
The consensus EPS estimate for EPAM Systems for the quarter ending Dec 31, 2026 is $3.61 from 20 analysts, with estimates from $3.42 to $3.78.
How often does EPAM beat earnings estimates?
EPAM Systems beat the EPS estimate in each of the last 37 quarters, with an average surprise of +9.56%.
EPAM pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors